The BRICS transcranial stimulation devices market is experiencing strong growth, driven by the rising prevalence of mental health disorders, increasing recognition of neuromodulation therapy as a non-invasive alternative, expanding healthcare infrastructure, and growing clinician acceptance of neuroplasticity-based treatments.
According to Business Market Insights, BRICS transcranial stimulation devices market was valued at US$ 123.9 million in 2025 and is expected to reach US$ 316.8 million by 2033, registering a CAGR of 12.5% during the forecast period from 2026 to 2033.
Transcranial stimulation devices, including Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS) systems, are used for non-invasive neuromodulation. These technologies support the treatment of cognitive and behavioral conditions as well as pain and sensory modulation, offering alternatives where conventional psychiatric care is limited.
Market Overview
The market is segmented by product type, application, and end user.
- By Product Type: Transcranial Magnetic Stimulation Devices hold the largest share. Transcranial Direct Current Stimulation Devices form the other key segment.
- By Application: Cognitive & Behavioral Regulation dominates the market. Pain & Sensory Modulation is the other major application segment.
- By End User: Hospitals lead the market, followed by Specialty Clinics, Ambulatory Surgical Centers, and Other End Users.
Get PDF: https://www.businessmarketinsights.com/sample/BMIPUB00035975
Key Growth Drivers and Opportunities
- Rising Mental Health Burden Growing incidence of mental health illnesses across BRICS nations is increasing demand for alternative treatment methods, especially where access to conventional psychiatric care is limited.
- Recognition of Neuromodulation Therapy Increasing clinician awareness of neuroplasticity benefits and the non-invasive nature of transcranial stimulation is supporting wider adoption.
- Healthcare Infrastructure Expansion Steady improvements in healthcare systems and technology adoption in major cities of Brazil, Russia, India, China, and South Africa are facilitating market growth. Investment in neurotechnologies and the opening of specialized neuromodulation clinics are expanding reach.
- Clinical Validation Clinical trials at leading metropolitan healthcare centers are helping validate product efficacy and build confidence among practitioners.
Regional Insights
The market covers the BRICS countries—Brazil, Russia, India, China, and South Africa. Growth is concentrated in urban and metropolitan areas where healthcare infrastructure and technology adoption are advancing. Emerging economies within the group are placing greater emphasis on technological solutions for mental illness treatment, creating a supportive environment for device development and implementation.
Competitive Landscape
The market is competitive, with several key players contributing to growth and innovation. Key players operating in the BRICS transcranial stimulation devices market include:
- eNeura Inc.
- Neuronetics
- BrainsWay Ltd.
- Soterix Medical Inc.
- Flow Neuroscience
- Magstim
- Nexstim
- Neurosoft
- Remed
- Halo Neuroscience
Get More Insights: https://www.businessmarketinsights.com/buy/BMIPUB00035975
Challenges
- High cost of medical devices relative to healthcare expenditure capacity in some areas.
- Limited access to neurological care in rural and suburban markets.
- Limited reimbursement policies.
- Inconsistencies in regulatory approaches across BRICS nations.
Future Outlook
- Continued expansion driven by rising demand for neurological services and advancement of healthcare systems.
- Growing clinician acceptance of neuromodulation solutions.
- Increased investment in neurotechnologies and specialized clinics.
- Broader clinical validation through trials in metropolitan centers.
- Steady market growth supported by the combination of mental health needs, infrastructure development, and non-invasive treatment preferences across BRICS countries.
The BRICS transcranial stimulation devices market is characterized by rapid expansion. As mental health awareness rises and healthcare systems modernize, demand for these advanced neuromodulation solutions is expected to continue growing across the region.
Frequently Asked Questions (FAQs)
How big is the BRICS Transcranial Stimulation Devices Market?
The BRICS Transcranial Stimulation Devices Market is valued at US$ 123.9 million in 2025 and is projected to reach US$ 316.8 million by 2033.
What is the CAGR for the BRICS Transcranial Stimulation Devices Market (2026–2033)?
The market is estimated to register a CAGR of approximately 12.5% during the forecast period.
What segments are covered in this report?
- Product Type (Transcranial Magnetic Stimulation Devices, Transcranial Direct Current Stimulation Devices)
- Application (Cognitive & Behavioral Regulation, Pain & Sensory Modulation)
- End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users)
Who are the major players in the BRICS Transcranial Stimulation Devices Market?
eNeura Inc., Neuronetics, BrainsWay Ltd., Soterix Medical Inc., Flow Neuroscience, Magstim, Nexstim, Neurosoft, Remed, and Halo Neuroscience.
More Trending Reports by Business Market Insights:
South and Central America Wearable Injectors Market
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us: If you have any questions about this report or would like further information, please contact us:
Contact person: Ankit Mathur
Email: [email protected]
Phone: +16467917070